These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France. Hommet C; Novella JL; Auriacombe S; Vercelletto M; Berrut G; Belliard S; Desmidt T; Ceccaldi M Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):274-86. PubMed ID: 27651009 [TBL] [Abstract][Full Text] [Related]
23. [Nonmedical treatment of dementia]. Hüll M; Voigt-Radloff S Nervenarzt; 2008 Nov; 79 Suppl 3():159-64; quiz 165-6. PubMed ID: 18931987 [TBL] [Abstract][Full Text] [Related]
24. New ways to approach manifestations of Alzheimer's disease and to reduce caregiver burden. Cohen-Mansfield J Int Psychogeriatr; 1996; 8 Suppl 1():91-4. PubMed ID: 8934273 [No Abstract] [Full Text] [Related]
25. Alzheimer's disease in real life--the dementia carer's survey. Georges J; Jansen S; Jackson J; Meyrieux A; Sadowska A; Selmes M Int J Geriatr Psychiatry; 2008 May; 23(5):546-51. PubMed ID: 18232054 [TBL] [Abstract][Full Text] [Related]
26. [Pharmacological treatment in severe dementia]. Jouanny P; Belliard S; Bentué-Ferrer D; Michel O; Allain H Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S51-5. PubMed ID: 15899605 [TBL] [Abstract][Full Text] [Related]
27. Different clinical effect of four antidementia drugs for Alzheimer's disease patients depending on white matter severity. Fukui Y; Hishikawa N; Ichinose J; Sato K; Nakano Y; Morihara R; Ohta Y; Yamashita T; Abe K Geriatr Gerontol Int; 2017 Nov; 17(11):1991-1999. PubMed ID: 28276131 [TBL] [Abstract][Full Text] [Related]
28. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)]. Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995 [TBL] [Abstract][Full Text] [Related]
29. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council. Fillit H; Cummings J Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691 [TBL] [Abstract][Full Text] [Related]
30. [Support for patients with Alzheimer's disease and their caregivers by gerontechnology]. Rigaud AS; Pino M; Wu YH; DE Rotrou J; Boulay M; Seux ML; Hugonot-Diener L; DE Sant'anna M; Moulin F; LE Gouverneur G; Cristancho-Lacroix V; Lenoir H Geriatr Psychol Neuropsychiatr Vieil; 2011 Mar; 9(1):91-100. PubMed ID: 21586382 [TBL] [Abstract][Full Text] [Related]
32. Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine. Kaufer DI; Borson S; Kershaw P; Sadik K CNS Spectr; 2005 Jun; 10(6):481-8. PubMed ID: 15908902 [TBL] [Abstract][Full Text] [Related]
33. Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden. Garfield FB; Getsios D; Caro JJ; Wimo A; Winblad B Pharmacoeconomics; 2002; 20(9):629-37. PubMed ID: 12141890 [TBL] [Abstract][Full Text] [Related]
34. EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I--Factors associated with carer burden. Schneider J; Murray J; Banerjee S; Mann A Int J Geriatr Psychiatry; 1999 Aug; 14(8):651-61. PubMed ID: 10489656 [TBL] [Abstract][Full Text] [Related]
35. Use of antidementia drugs in German patients with Alzheimer's disease. Hessmann P; Dodel R; Baum E; Müller MJ; Paschke G; Kis B; Zeidler J; Klora M; Reese JP; Balzer-Geldsetzer M Int Clin Psychopharmacol; 2018 Mar; 33(2):103-110. PubMed ID: 29112517 [TBL] [Abstract][Full Text] [Related]
36. [Quality of life and dementia]. Lucas Carrasco R Med Clin (Barc); 2007 Jan; 128(2):70-5. PubMed ID: 17266905 [TBL] [Abstract][Full Text] [Related]
38. Caregiver burden: three voices-three realities. Wright JF; Doherty ME; Dumas LG Nurs Clin North Am; 2009 Jun; 44(2):209-21. PubMed ID: 19463677 [TBL] [Abstract][Full Text] [Related]
39. Modelling the clinical and economic implications of galantamine in the treatment of mild-to-moderate Alzheimer's disease in Germany. Guo S; Hernandez L; Wasiak R; Gaudig M J Med Econ; 2010; 13(4):641-54. PubMed ID: 20958114 [TBL] [Abstract][Full Text] [Related]
40. [Alzheimer dementia: course and burden on caregivers : Data over 18 months from German participants of the GERAS study]. Hager K; Henneges C; Schneider E; Lieb M; Kraemer S Nervenarzt; 2018 Apr; 89(4):431-442. PubMed ID: 28674749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]